In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ryan Nelson

Executive Editor

Washington, D.C.
Ryan Nelson is managing editor of Informa’s Rose Sheet and the head of its cosmetics content channel, with particular expertise in evolving regulatory and legal issues. He’s been covering FDA-regulated industries for going on 15 years, previously reporting for the Gray Sheet (now Medtech Insight) where he handled beats including Capitol Hill and Emerging Technology. He began his career teaching English Literature to 9th grade boys at a private boarding school in Chattanooga, Tennessee, a role he misses only occasionally. Ryan is based in Informa’s Washington, D.C. office.

Latest From Ryan Nelson

Senate HELP Floats Draft For US Cosmetics Reform; Top Trade Groups Hustle To Respond

Bundled within the draft FDA Safety and Landmark Enhancements Act are federal cosmetics reform provisions that would require facility registration and product listings with the US FDA, adverse event reporting and good manufacturing practices, while empowering the agency to order product recalls, access company records, and suspend dangerous operations.

United States Regulation

REACH Information Requirements Have Changed; ECHA Preparing Guidance

The European Chemicals Agency is targeting the back half of 2022 for guidance on revised information requirements for substances registered under REACH, following a European Commission regulation published in March.

Europe Regulation

Inter Parfums’s Q1 Sales Up 26% In ‘Robust Environment’ For Fragrance

The New York-based manufacturer of prestige perfumes and cosmetics is “extremely optimistic” about fiscal 2022 and the years ahead, recording net sales growth of 26% in the first quarter, led by major brand innovations, and projecting an 11% increase for the full year.

Beauty Sales & Earnings

Babyganics Recalls Selected Bubble Baths Due To Potential Contamination

The SC Johnson brand is providing full refunds to consumers who purchased the chamomile verbena Bubble Bath products, which may contain a bacterium that is potentially harmful to the immunocompromised and those with broken or irritated skin, “such as diaper rash.”

Cosmetics Recalls

US FDA Warning Letter Salvo: No Such Thing As Approved OTC Skin-Lightening Product

The FDA issued warning letters to a dozen companies about marketing OTC skin-lightening products containing hydroquinone. While the agency’s stance was friendlier toward such products when it launched the OTC drug review program 40 years ago, the program has changed, and so have the FDA’s views on hydroquinone.

FDA OTC Drugs

J&J Commits To Supply Chain Reforms In Benzene Class Action Settlement

Already in receipt of more than $9m in refund requests from purchasers of potentially benzene-contaminated Neutrogena and Aveeno sunscreen products following a July 2021 recall, J&J now is finalizing a US multidistrict class action settlement that will add to those costs and require steps to prevent further benzene issues.

United States Supply Chain
See All
UsernamePublicRestriction

Register